Abstract:Objective: To evaluate a mouse model of chronic obstructive pulmonary disease (COPD) induced by intraperitoneal injections of cigarette smoke extract (CSE), and to study the potential mechanisms. Methods: Mice were injected intraperitoneally with CSE at different time points to establish a mouse model of COPD. Mouse lung mechanics parameters were measured, and the total numbers and differentials of cells in bronchoalveolar lavage fluid (BALF) were counted. Pathological changes of lung tissue were observed and mean linear intercept (MLI) and alveolar destructive index (DI) were measured. The expressions of matrix metalloproteinases-12(MMP12), neutrophil elastase (NE),tissue inhibitor of metalloproteinase-1(TIMP1), pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), Th1 cytokines (IFN-γ), Th2 cytokines (IL-5, IL-13) and the neutrophil chemokine KC were determined in the lungs of all mice. Results: Significant increase of total lung capacity(TLC) [(0.73 ± 0.02), (0.83 ± 0.04), (0.97 ± 0.02)ml] was found in the CSE group as compared with the PBS control group [(0.65 ± 0.01), (0.67 ± 0.02), (0.71 ± 0.04)ml, t= 4.109, 3.666, 5.994, P<0.01] at day 21, 41, 61. Lung compliance was higher in the CSE group [(0.041 ± 0.002) ml/cmH2O (1 cmH₂O= 0.098 kPa), (0.039 ± 0.001) ml/cmH₂O] than the PBS control group [(0.030 ± 0.001) ml/cmH₂O, (0.032 ± 0.003) ml/cmH₂O, t= 4.788,2.508, P<0.05] at day 41,61, but airway resistance in the lungs (R) was lower in the CSE group [(0.959 ± 0.016) cmH₂O·s·ml⁻¹, (0.976±0.020) cmH₂O·s·ml⁻¹] than the PBS control group [(1.043 ± 0.022) cmH₂O·s·ml(-1), (1.085±0.043) cmH₂O·s·ml⁻¹] (t= 2.928,2.321, P<0.05). The total numbers of BALF cells in the CSE group [(23.83 ± 2.63)×10⁴, (20.67±1.69)×10⁴, (18.67±1.56) × 10⁴] were increased compared with the PBS control group [(7.33 ± 0.61)×10⁴, (7.67 ± 0.76)×10⁴, (6.67 ± 0.88)×10⁴, t= 6.119,7.027,6.685,P<0.01] at day 21,41,61, predominantly with neutrophils and macrophages. Typical COPD pathological changes of lung tissue were evident, including Inflammatory cell infiltration in the lung parenchyma and increased mean linear intercept (MLI) in the CSE group [(48.0 ± 1.4), (56.1 ± 2.4), (59.3 ± 3.3)µm] as compared with the PBS control group [(40.5 ± 1.2), (43.7 ± 1.2), (43.5 ± 1.2)µm, t= 4.015,4.695,4.612, P<0.01] as well as increased alveolar destructive index (DI) in the CSE group [(15.2 ± 1.3)%, (22.4 ± 1.3)%, (23.8 ± 1.0)%] as compared with the PBS control group [(11.1 ± 0.9)%, (10.8 ± 1.0)%, (12.4 ± 0.7)%,t= 2.532, 7.225, 8.471, P < 0.05] at the 3 time points. The expressions of MMP12 and NE increased significantly in the CSE-treated mice. Pro-inflammatory cytokines (TNF-α, IL-1β, L-6), Th1 cytokine IFN-γ and KC all increased significantly in the CSE-treated mice as compared with the PBS-control mice. Conclusions: A mouse model of COPD was successfully established by repeated intraperitoneal injections of CSE in a shorter period of time. Local inflammation and proteinase/anti-proteinase imbalance as a result of CSE-induced immunological responses may be the underlying mechanisms.

Differential Requirement of C3a Receptor in APC-driven Emphysema in Response to Cigarette Smoke (P6225)

Autophagy Protein Microtubule-Associated Protein 1 Light Chain-3b (Lc3b) Activates Extrinsic Apoptosis During Cigarette Smoke-Induced Emphysema

Cigarette smoke-induced reduction of C1q promotes emphysema

Loss Of Peripheral Tolerance In Emphysema Phenotypes, Exacerbations, And Disease Progression

Cigarette Smoke Induction of Osteopontin (SPP1) Mediates T(H)17 Inflammation in Human and Experimental Emphysema.

WNT/β-catenin Signaling Regulates Cigarette Smoke-Induced Airway Inflammation Via the PPARδ/p38 Pathway

Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model.

Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway

Cigarette smoke with IL-33 delivery leads to an exacerbated phenotype and hallmarks of mixed type 1/type 2 lung inflammation in mice

Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent.

Agonistic Induction of PPARγ Reverses Cigarette Smoke-Induced Emphysema.

Cigarette Smoking Contributes to Th1/Th2 Cell Dysfunction via the Cytokine Milieu in Chronic Obstructive Pulmonary Disease

Emphysema is Associated with Increased Inflammation in Lungs of Atherosclerosis-Prone Mice by Cigarette Smoke: Implications in Comorbidities of COPD.

Response to Comment on “cigarette Smoke-Induced Pulmonary Inflammation is TLR4/MyD88 and IL-1R1/MyD88 Signaling Dependent”

Nanoparticulate Carbon Black in Cigarette Smoke Induces DNA Cleavage and Th17-mediated Emphysema.

Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice

[Evaluation of a mouse model of chronic obstructive pulmonary disease induced by intraperitoneal injections of cigarette smoke extract]

Upregulation of IL-17A/F from Human Lung Tissue Explants with Cigarette Smoke Exposure: Implications for COPD

PU.1 alleviates the inhibitory effects of cigarette smoke on endothelial progenitor cell function and lung-homing through Wnt/β-catenin and CXCL12/CXCR4 pathways

Early growth response factor 1 is essential for cigarette smoke-induced MUC5AC expression in human bronchial epithelial cells

Intraperitoneal injection of cigarette smoke extract induced emphysema, and injury of cardiac and skeletal muscles in BALB/C mice.